(Q29617440)
Statements
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer (English)
Vogel CL
Cobleigh MA
Tripathy D
Gutheil JC
Harris LN
Fehrenbacher L
Slamon DJ
Murphy M
Novotny WF
Burchmore M
Shak S
Stewart SJ
Press M
1 February 2002
20
719-26